The research focus of Jlenia Guarnerio, MS, PhD, is to understand the molecular and cellular mechanisms of cancer. She is investigating both cell-autonomous mechanisms responsible for cancer progression (e.g., tumor genetics), as well as the non-cell-autonomous ones (e.g., factors derived from the tumor microenvironment). She combines techniques of RNA-sequencing, molecular biology and Crispr/Cas9 technologies, together with the use of mouse models. Her ultimate goal is to identify novel therapeutic interventions for cancer and new strategies of precision medicine.

• Doctorate: University San Raffaele, Milan Italy, 2012
• Post Doctorate: Harvard Medical School, 2018